Rahul Singhvi

Rahul Singhvi

Directeur/Membre du Conseil chez KAIROS PHARMA, LTD.

Fortune : 311 876 $ au 30/06/2026

61 ans
Health Technology
Commercial Services
Consumer Services

Profil

Rahul Singhvi founded National Resilience, Inc. in 2020, where he worked as CO-Chief Executive Officer & Director from 2020 to 2025.
Dr. Singhvi also founded Axella Solutions LLC, where he is working as Managing Partner, Resilience Biotechnologies, Inc., where he is working as Chief Executive Officer, and Axella Biosciences, Inc., where he is working as President, Secretary, Treasurer & Director.
Dr. Singhvi also currently works at Swiftscale Biologics, Inc., as Chief Executive Officer, Codexis, Inc., as Independent Director from 2022, Stratus Therapeutics, Inc., as Director, Kairos Pharma Ltd., as Independent Director from 2024, Tag1 Consulting, Inc., as Director from 2024, and Keck Graduate Institute of Applied Life Sciences, as Trustee.
Dr. Singhvi also formerly worked at Novavax, Inc., as President & Chief Executive Officer from 2005 to 2011, Merck & Co., Inc., as Director-Manufacturing Division from 1999 to 2004, ImmunoCellular Therapeutics Ltd., as Lead Independent Director from 2011 to 2018, NewGen BioPharma Corp., as Director, Univercells SA, as Director, Valor Biotherapeutics LLC, as Director, Magnum Hunter Resources, Inc., as Chief Operating Officer, Bill, Hillary & Chelsea Clinton Foundation, as Member, Ring Therapeutics, Inc., as President from 2019 to 2020, Caliber Biotherapeutics LLC, as Managing Partner, Takeda Vaccines, Inc., as Chief Operating Officer, Flagship Pioneering, LLC, as Operating Partner from 2019 to 2020, Takeda Pharmaceutical Co., Ltd., as Chief Operating Officer from 2013 to 2019, and Flagship Pioneering, LLC, as Partner.
Dr. Singhvi received his graduate degree and doctorate degree from Massachusetts Institute of Technology, undergraduate degree from Indian Institute of Technology Kanpur, and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
17/06/2026 137 052 ( 0,15% ) 309 738 $ 30/06/2026
31/03/2026 5 569 ( 0,03% ) 2 138 $ 30/06/2026

Postes actifs de Rahul Singhvi

SociétésPosteDébut
CODEXIS, INC. Directeur/Membre du Conseil 28/09/2022
KAIROS PHARMA, LTD. Directeur/Membre du Conseil 10/12/2024
Directeur/Membre du Conseil 01/10/2024
Directeur/Membre du Conseil -
Directeur Général -
Directeur Général -
Directeur/Membre du Conseil -
Axella Solutions LLC
Fondateur -

Anciens postes connus de Rahul Singhvi

SociétésPosteFin
Fondateur 01/01/2025
░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Rahul Singhvi

Formation de Rahul Singhvi

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

65

Relations au 1er degré

25

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées25

Health Technology

Health Technology

Energy Minerals

Process Industries

Health Technology

Health Technology

Finance

Finance

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Consumer Services

Axella Solutions LLC

Commercial Services

Commercial Services

Valor Biotherapeutics LLC

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Rahul Singhvi